Translating multiscale cancer models into clinical trials: Simulating breast cancer tumor dynamics within the framework of the "Trial of Principle" clinical trial and the ACGT project

8th IEEE International Conference on BioInformatics and BioEngineering, BIBE 2008

Volumn , Issue , 2008, Pages

  Kolokotroni, Eleni A ^a   Stamatakos, Georgios S ^a   Dionysiou, Dimitra D ^a   Georgiadi, Eleni Ch ^a,b   Desmedt, Christine ^c   Graf, Norbert M ^d  

^a INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS   (Greece)

^b INSTITUTE OF COMPUTER SCIENCE   (Greece)

^c JULES BORDET INSTITUTE   (Belgium)

^d SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST CANCER TUMORS; CANCER MODELS; CANCER TREATMENT; CLINICAL DATA; CLINICAL INFORMATION; CLINICAL PRACTICES; CLINICAL TRIAL; COMPUTER MODELS; DEAD CELLS; DISCRETE STATE; DYNAMICS MODELS; EPIRUBICIN; EUROPEAN COMMISSION; IN-SILICO; MULTILEVEL MODELING; MULTISCALE; OPTIMIZATION PROCESS; TRANSITION RATES; TREATMENT OPTIMIZATION; TUMOR GROWTH;

BIOINFORMATICS; DYNAMICS; OPTIMIZATION; PATIENT TREATMENT;

TUMORS;

EID: 67549122648     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/BIBE.2008.4696758     Document Type: Conference Paper

References (17)

1. World Health Organization International Agency for Research on Cancer (June 2003). World Cancer Report. Retrieved on 2008-06-17.
2. B Fisher, J Bryant, N Wolmark, E Mamounas, A Brown, ER Fisher, DL Wickerham, M Begovic, A DeCillis, A Robidoux, RG Margolese, AB Cruz Jr, JL Hoehn, AW Lees, NV Dimitrov and HD Bear, "Effect of preoperative chemotherapy on the outcome of women with operable breast cancer," J. Clin. Oncol., vol. 16, pp. 2672-85, 1998.
3. S. Chuang, "Mathematic models for cancer chemotherapy: pharmacokinetic and cell kinetic considerations," Cancer Chemother. Rep,vol. 59, no. 4, pp. 827-42, 1975.
4. S. Ozawa, Y. Sugiyama, J. Mitsuhashi, and M. Inaba, "Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and chinese hamster cells," Cancer Res., vol. 49, pp. 3823-3828, 1989.
5. S. N. Gardner, "Modeling multi-drug chemotherapy: Tailoring treatment to individuals," J. Theor. Biol., vol. 214, pp. 181-207, 2002.
6. V. Durbecq, M. Paesmans, F. Cardoso, C. Desmedt, A. Di Leo, S. Chan, K. Friedrichs, T. Pinter, S. Van Belle, E. Murray, I. Bodrogi, E. Walpole, B. Lesperance, S. Korec, J. Crown,11 P. Simmonds, T. J. Perren, J.-Y. Leroy, G. Rouas, C. Sotiriou, M. Piccart, and D. Larsimont, "Topoisomerase-IIA expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel," Mol Cancer Ther, vol. 3, pp. 1207-1214, October 2004
7. G.S. Stamatakos, D.D. Dionysiou, E.I. Zacharaki, N.A. Mouravliansky, K.S.Nikita, N.K. & Uzunoglu, In silico radiation oncology: combining novel simulation algorithms with current visualization techniques, IEEE Proceedings: Special Issue on Bioinformatics: Advances and Chalenges, 90(11), 1764-1777, 2002.
8. D. D. Dionysiou, G. S. Stamatakos, N.K. Uzunoglu, K. S. Nikita, A. Marioli, "A four-dimensional simulation model of tumour response to radiotherapy in vivo: parametric validation considering radiosensitivity, genetic profile and fractionation,"Journal of Theoretical Biology vol. 230, pp. 1-20, 2004
9. G. S. Stamatakos, V. P. Antipas and N. K. Uzunoglu, "A Spatiotemporal, Patient Individualized Simulation Model of Solid Tumor Response to Chemotherapy in Vivo: The Paradigm of Glioblastoma Multiforme Treated by Temozolomide," IEEE Transactions On Biomedical Engineering, vol. 53, pp. 1467- 1477, August 2006
10. G.S. Stamatakos, D.D. Dionysiou, N.M. Graf, N.A. Sofra, C. Desmedt, A. Hoppe, N. Uzunoglu, M. Tsiknakis, "The Oncosimulator: a multilevel, clinically oriented simulation system of tumor growth and organism response to therapeutic schemes. Towards the clinical evaluation of in silico oncology," Proceedings of the 29th Annual International Conference of the IEEE EMBS Cite Internationale, August 23-26, SuB07.1: 6628-6631, Lyon, France, 2007
11. G. Steel, Basic Clinical Radiobiology. Arnold, London, UK. 2002.
12. S.E.Salmon and A.C.Sartorelli "Cancer Chemotherapy", in Basic & Clinical Pharmacology, B.G. Katzung, ed. Lange Medical Books/McGraw-Hill, International Edition, pp.923-1044, 2001.
13. R. Danesi, F. Innocenti, S. Fogli, A.Gennari, E.Baldini, A.Di Paolo, B.Salvadori, G.Bocci, P.F.Conte and M.Del Tacca, "Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients", Journal of Clinical Pharmacology, vol. 53, pp 508-518, 2002.
14. http://depts.washington.edu/saam2/
15. M.C.Perry ed. The Chemotherapy Source Book. USA, Philadelphia: Lippincott Williams &Wilkins, 2008.
16. http://www.fda.gov/cder/foi/nda/99/50-778-Ellence-pharmr.pdf
17. J.Lankelma, H.Dekker, R.F. Luque, S.Luykx, K.Hoekman, P.van der Valk, P.J.van Diest, H.M.Pinedo, " Doxorubicin gradients in human breast cancer," Clin Cancer Res, vol. 5, pp. 1703-1707, 1999.